Syneos Health Names Jeanine O’Kane as Communications President
April 04 2023 - 2:05PM
Syneos Health® (Nasdaq: SYNH), a leading fully integrated
biopharmaceutical solutions organization, today announced Jeanine
O’Kane as President of Syneos Health Communications — a portfolio
of agencies spanning advertising, public relations, patient
advocacy, medical communications, managed markets, and naming and
branding. Formally President of the US Public Relations Group at
Syneos Health Communications, Jeanine has been with the
organization for more than a decade and has more than 20 years of
industry experience.
During her tenure at Syneos Health Communications, she has been
instrumental in developing award-winning communications programs
and has helped integrate communications and commercial expertise
into clinical development – unlocking innovative solutions to
deliver life-saving therapies to patients worldwide.
“Our Syneos Health Communications team plays a fundamental role
in our integrated operating model – helping us better understand
patient, provider and policy maker needs and behaviors, to develop
strategies to enable our customers’ success,” said Michael Brooks,
Chief Operating Officer, Syneos Health. “With science evolving at a
record pace, we are excited for Jeanine to take on her new role as
President, continuing to advance innovative solutions, to drive
growth and enterprise value.”
“Every day, Syneos Health Communications operates at the Heart
of Health – helping customers predict what’s next and respond to
the market’s demand for smarter and faster answers,” said Jeanine
O’Kane, President, Syneos Health Communications. “For more than a
decade, I’ve witnessed the forward-thinking, impactful work this
portfolio of agencies designs and delivers for our customers. I
look forward to driving strong momentum in this new role and I’m
excited for what’s next.”
Syneos Heath Communications is known for its award-winning,
insights-based communications programs that resonate emotionally,
nurture motivation and accelerate customer success. Award winning
agencies include Addison Whitney, Biosector 2, BoldSky Creative
Studio, Cadent, Chamberlain Healthcare Public Relations, Chandler
Chicco Agency, GSW, Litmus, Genicos and Spherico.
About Syneos HealthSyneos Health® (Nasdaq:
SYNH) is a leading fully integrated biopharmaceutical solutions
organization built to accelerate customer success. We translate
unique clinical, medical affairs and commercial insights into
outcomes to address modern market realities.
We bring together a talented team of professionals, who work
across more than 110 countries, with a deep understanding of
patient and physician behaviors and market dynamics.
Together we share insights, use the latest technologies and
apply advanced business practices to speed our customers’ delivery
of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive
culture that cares for colleagues, customers, patients, communities
and the environment.
To learn more about how we are Shortening the distance
from lab to life®, visit syneoshealth.com
or subscribe to our podcast.
Investor Relations Contact: |
Press/Media Contact: |
Ronnie Speight |
Gary Gatyas |
Senior Vice President, Investor Relations
|
Executive Director, External Communications |
+1 919 745 2745 |
+1 908 763 3428 |
Investor.Relations@syneoshealth.com |
gary.gatyas@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024